UK Neuroscientist and Psychology Professor Dr. Michael Bardo Studies a New Medication to Treat Opioid Use Disorder

Dr. Michael Bardo and his laboratory have recently completed studies demonstrating that the stress-hormone receptor blocker “PT150”, a gift of Palisades Therapeutics in New Jersey, reduces fentanyl seeking in addicted laboratory rats following a stressful event. This research, funded by the U.S. Department of Defense, suggests that targeting stress systems may be an effective way to treat opioid relapse among those seeking treatment. A new grant application, with collaborator Dr. Craig Rush from the College of Medicine, is being prepared to test the potential efficacy of PT150 in humans.